News & Articles

Explore topics from LC-MS for oligos, peptides, glycans, and large molecule characterization to 3D cell culture for anticancer therapies

KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology

COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study

A new Prenetics Innovation Technology Centre will be established for advanced molecular diagnostics

Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse

Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems

An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies

Keep up to date with the latest research and discover the tools and techniques advancing 3D cell culture and its applications

Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up

AI could hold the key to more targeted treatment, according to new research

Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs

Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more

Reserve your place today for talks on topics ranging from food fraud, spatial infiltration and CRISPR to antibody and AAV gene therapies

Explore topics from food fraud and flow cytometry to pharmaceutical solid-phase microextraction and vaccine, cell & gene therapy production

Discover how a brain organoid core facility is applying its glioblastoma model towards developing patient mini-brains

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant